About Elfin Pharma Private Limited
Data last updated:
Elfin Pharma Private Limited is a private limited company based in Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 July 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231PB1999PTC022779. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹19.58 Lakh. It is led by directors including Dilpreet Singh (Managing Director) and Manpreet Kaur (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E 206 Phase VIII Bbindustrial Area Focal Point Sas Nagar, Punjab, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.8 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.46 Cr (net margin 80.7%) and EBITDA of ₹1.8 Cr (EBITDA margin 99.9%). Revenue has grown at a compounded annual rate (CAGR) of 193% over three years and 157% over five years.
The company is associated with 1 brand: Elfin Pharma. As per MCA filings, the company has open charges of ₹7.15 Cr and satisfied charges of ₹17.23 Cr on record. Court records list 8 cases involving the company, including 3 filed by the company and 5 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elfinpharma.com.
Company details
Contact details
Elfin Pharma Private Limited's registered office is in Punjab. Its website is elfinpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressE 206 Phase VIII Bbindustrial Area Focal Point Sas Nagar, Punjab, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Elfin Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Elfin Pharma operates one associated brand: Elfin Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, exporting, and supplying of drugs in India. | elfinpharma.com |
Financials of Elfin Pharma Private Limited
FY 2025 filings availableElfin Pharma Private Limited reported revenue of ₹1.8 Cr (up 821% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 157% over five years, including 821% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.8 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.46 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 99.9% | ||||
| Net Profit Margin | 80.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elfin Pharma Private Limited, buy the company report.
Board of directors of Elfin Pharma Private Limited
Elfin Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gurinder Kaur Makkar | Director | 28 Apr 2004 | 22 Years 6 Months | Current |
| Manpreet Kaur | Whole-Time Director | 15 Feb 2001 | 25 Years 8 Months | Current |
| Dilpreet Singh Also directs: Elfin Drugs Private Limited | Managing Director | 15 Feb 2001 | 25 Years 8 Months | Current |
Peer comparison
Elfin Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nectar Laboratories Private Limited | ₹1.83 Cr (FY 2025) | -76.0% | Hyderabad, Telangana, India | |||
| Replica Remedies Private Limited | ₹1.81 Cr (FY 2019) | -60.0% | Ahmedabad, Gujarat, India | |||
| Elfin Pharma Private Limitedthis company | ₹1.8 Cr (FY 2025) | ₹1.46 Cr | 80.7% | 821.0% | Punjab, India | |
| Iutex International Private Limited | ₹1.8 Cr (FY 2025) | 3.0% | Delhi, India | |||
| Gladcare Formulations Private Limited | ₹1.8 Cr (FY 2024) | -6.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Elfin Pharma Private Limited, buy the company report.
Auditor
Elfin Pharma Private Limited is audited by R. TREHAN & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. TREHAN & ASSOCIATES | FY 2024 | 007582N |
Shareholding
The shareholding of Elfin Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Elfin Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jul 2012 | 10373742 | The Karur Vysya Bank Limited | ₹12 Lakh | Open | |
| 21 Feb 2006 | 80026755 | Oriental Bank of Commerce | ₹5.54 Cr | Open | |
| 27 Nov 2002 | 80026752 | State Bank of Patala | ₹65 Lakh | Open | |
| 27 Nov 2002 | 90311804 | State Bank of Patiala | ₹54 Lakh | Open | |
| 27 Nov 2002 | 90312341 | State Bank of Patiala | ₹30 Lakh | Open |
To see the full charge records of Elfin Pharma Private Limited, buy the company report.
Total charge records: 14 View all charges
Legal cases
Elfin Pharma Private Limited has 8 court cases on record: 3 filed by Elfin Pharma, 5 filed against it. 2 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 4 | 2 |
| High courts | 2 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Civil suit | Filed against the company by BKRS Pharma Pvt Ltd | Pending |
| District court, Gurugram, Haryana | Civil suit | Filed against the company by Pectro Biotecch Pvt Ltd | Pending |
| High Court of Punjab and Haryana | Writ petition | Filed by the company against State of Punjab Through Its Secretary | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against individuals | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
To see the full case history of Elfin Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elfin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Elfin Pharma Private Limited has 1 active EPFO establishment as of Oct 08, 2025.
GST
Elfin Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Elfin Pharma Private Limited, buy the company report.
Recent activity
Elfin Pharma Private Limited has 6 board changes on record since 2001: 3 appointments and 3 cessations. The latest: Shashi Kumar Sahai ceased to be Additional Director on 25 Oct 2012.
25 earlier events are in the company report.
Frequently asked questions
Elfin Pharma is an active private limited company based in Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 July 1999 (27+ years old) and is registered under CIN U24231PB1999PTC022779.
Elfin Pharma has 3 current directors:
- Dilpreet Singh - Managing Director
- Manpreet Kaur - Whole-Time Director
- Gurinder Kaur Makkar - Director
The latest financial statements of Elfin Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Elfin Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Elfin Pharma is U24231PB1999PTC022779. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elfin Pharma has 8 court cases on record: 3 filed by the company and 5 filed against it. 2 are pending. Most are in the district courts.
Elfin Pharma was incorporated on 14 July 1999, making it 27+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Elfin Pharma by revenue are Nectar Laboratories Private Limited, Replica Remedies Private Limited, Iutex International Private Limited, Gladcare Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shashi Kumar Sahai ceased to be Additional Director on 25 Oct 2012. Abhey Pal Singh ceased to be Director on 05 Oct 2012. Harsimran Kaur Sodhi ceased to be Director on 05 Oct 2012. Elfin Pharma has 6 board changes on record in total.
Elfin Pharma can be reached through the website elfinpharma.com. Its registered office is in Punjab, India.
The registered office of Elfin Pharma is at E 206 Phase VIII Bbindustrial Area Focal Point Sas Nagar, Punjab, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
